Clinical Trial Update: A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated tolerability and efficacy of tamsulosin 0.4 mg OCAS in patients with LUTS due to benign prostatic hyperplasia who were dissatisfied wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) | Phase 4 | Status: COMPLETED